Ticker: IBB CUSIP: 464287556 Class: ISHARES BIOTECH
Note: Option positions (PUT/CALL) are excluded.
| Period | Shares | Value ($000) | Average Close | Price Range |
|---|---|---|---|---|
| Q4 2025 | 1,204,046 | $203,207 | — | — |
| Q3 2025 | 2,547,870 | $367,836 | — | — |
| Q2 2025 | 2,482,142 | $314,016 | — | — |
| Q1 2025 | 529,604 | $67,736 | — | — |
| Q4 2024 | 856,639 | $113,256 | — | — |
| Q3 2024 | 1,367,178 | $199,061 | — | — |
| Q2 2024 | 3,153,868 | $432,900 | — | — |
| Q1 2024 | 3,212,765 | $440,856 | — | — |
| Q4 2023 | 2,178,849 | $295,997 | — | — |
| Q3 2023 | 2,421,484 | $296,123 | — | — |
| Q2 2023 | 1,109,994 | $140,925 | — | — |
| Q1 2023 | 1,829,897 | $236,350 | — | — |
| Q4 2022 | 1,874,113 | $246,052 | — | — |
| Q3 2022 | 1,314,529 | $154 | — | — |
| Q2 2022 | 1,546,877 | $182 | — | — |
| Q1 2022 | 1,568,159 | $204,332 | — | — |
| Q4 2021 | 1,172,739 | $178,983 | — | — |
| Q3 2021 | 2,255,375 | $364,649 | — | — |
| Q2 2021 | 1,980,796 | $324,157 | — | — |
| Q1 2021 | 3,257,669 | $490,475 | — | — |
| Q4 2020 | 6,174,322 | $935,349 | — | — |
| Q3 2020 | 3,540,283 | $479,390 | — | — |
| Q2 2020 | 6,444,162 | $880,853 | — | — |
| Q1 2020 | 4,137,123 | $445,734 | — | — |
| Q4 2019 | 4,465,797 | $538,173 | — | — |
| Q3 2019 | 2,745,802 | $273,207 | — | — |
| Q2 2019 | 2,088,721 | $227,880 | — | — |
| Q1 2019 | 3,215,584 | $359,503 | — | — |
| Q4 2018 | 1,518,883 | $146,466 | — | — |
| Q3 2018 | 2,121,496 | $258,695 | — | — |
| Q2 2018 | 3,604,540 | $395,851 | — | — |
| Q1 2018 | 2,084,991 | $222,552 | — | — |
| Q4 2017 | 2,710,598 | $289,410 | — | — |
| Q3 2017 | 1,336,930 | $445,986 | — | — |
| Q2 2017 | 1,064,790 | $330,170 | — | — |
| Q1 2017 | 1,678,018 | $492,112 | — | — |
| Q4 2016 | 1,025,558 | $272,163 | — | — |
| Q3 2016 | 1,629,011 | $471,534 | — | — |
| Q2 2016 | 1,697,174 | $436,750 | — | — |
| Q1 2016 | 2,195,489 | $572,606 | — | — |
| Q4 2015 | 2,641,355 | $893,649 | — | — |
| Q3 2015 | 3,119,663 | $946,288 | — | — |
| Q2 2015 | 2,622,638 | $967,675 | — | — |
| Q1 2015 | 2,921,090 | $1,003,190 | — | — |
| Q4 2014 | 2,077,846 | $630,314 | — | — |
| Q3 2014 | 3,824,816 | $1,046,584 | — | — |
| Q2 2014 | 3,358,873 | $863,331 | — | — |
| Q1 2014 | 3,015,237 | $712,802 | — | — |
| Q4 2013 | 2,354,637 | $534,644 | — | — |
| Q3 2013 | 1,454,249 | $304,811 | — | — |
| Q2 2013 | 1,510,246 | $262,602 | — | — |
| Q4 2012 | 779,660 | $106,985 | — | — |
| Q3 2012 | 1,549,691 | $220,970 | — | — |
| Q2 2012 | 1,520,361 | $197,579 | — | — |
| Q1 2012 | 1,054,377 | $130,005 | — | — |